Compositions and uses of a galectin for treatment of dry eye...

Details Compositions and uses of a galectin for treatment of dry eye... Compositions and uses of a galectin for treatment of dry eye...

2007-03-13

2007-03-13

Wax, Robert A. (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000

Reexamination Certificate

active

11104677

ABSTRACT:
Methods for the therapeutic treatment of dry eye in mammals comprising administering to a mammal afflicted with an epithelial wound a therapeutically effective amount of a galectin-1 protein, a galectin-3, a galectin-7 protein and/or a galectin-8 protein are provided. Pharmaceutical and ophthalmic compositions and kits, comprising a pharmaceutically an active agent which is a galectin-1 protein, a galectin-3 protein, galectin-7 protein and/or a galectin-8 protein, and a suitable carrier or a diluent, are provided.

REFERENCES:
patent: 6967021 (2005-11-01), Panjwani et al.
patent: 2002/0044932 (2002-04-01), Liu et al.
Sall et al., Two Multicenter, Randomized Studies of the Efficacy and Safety of Cylosporine Ophthalmic Emulsion in Moderate to Severe Dry Eye Disease, Ophthalmology, 2000, vol. 107, pp. 631-639.
Solomon et al., Pro- and Anti-inflammatory Forms of Interleukin-1 in the Tear Fluid and Conjunctiva of Patients with Dry-Eye Disease, Investigative Ophthalmology & Visual Science, 2001, vol. 42, pp. 2283-2292.
Accession No. AAB02856 in GenBank.
Accession No. BAA22164 in GenBank, Seq Id No. 1.
Accession No. CAA55479 in GenBank.
Accession No. I55469 in GenBank, Seq Id No. 2.
Accession No. JC4300 in GenBank.
Accession No. O54974 in GenBank.
Accession No. P97590 in GenBank.
Accession No. O00214 in GenBank.
Accession No. Q8TEV1 in GenBank.
Abelson et al., 2003, Rev Ophthalmol 10:1.
Bernerd et al., 1999, Proc. Natl. Acad. Sci. USA 96:11329-11334.
Bresalier et al., 1996, Cancer Res 56:4354-4357.
Brewitt et al. 2001, Surv of Ophthalmol 45:S199-S202.
Burgalassi et al., 1999, Ophthalm Res 31:229-235.
Cao et al., 2002, J Biol Chem 277:42299-42305.
CAO et al., 2003, Arch Ophthalmol 121:82-86.
Cherayil et al., 1990, Proc. Natl. Acad. Sci. USA 87:7324-7328.
Dagher et al., 1995, Proc. Natl. Acad. Sci. USA 92:1213-1217.
Danjo et al., 1998, Invest Ophthalmol Vis Sci 39:2602-2609.
Dursun et al., 2002, Invest Ophthamol & Vis Sci 43:632-638.
Foulks, 2003, The Ocular Surface, 1:20-30.
Gamache et al., 2000, Cornea 19:6:S88.
Gilbard, 2000, “Dry-eye Disorders,” In: Albert M et al., ed. Principles and Practice of Ophthalmology: 2nd Edition, Philadelphia: W.B. Saunders Company: 982-1001.
Gipson et al., 1997, Prog Retinal Eye Res 16:1:81-98.
Hadari et al., 1997, Trends in Glycosci and Glycotechnol 9:103-112.
Hsu et al., 2000, Am J Pathol 156:1073-1083.
Jabs et al., 1991, Invest Opthamol Vis Sci 32:371-380.
Jabs et al., 1997, Curr Eye Res 16:909-916.
Jeng et al., 1994, Immunol Lett 42:113-116.
Jumblatt et al., 1998, Exp Eye Res 67:341-346.
Leonidas et al., 1998, Biochemistry 37:13930-13940.
Liu, 2000, Clin Immunology 97:79-88.
Liu et al., 1996, Biochemistry 35:6073-6079.
Madsen et al., 1995, J Biol Chem 270:5823-5829.
Magnaldo et al., 1995, Develop Biol 168:259-271.
Matarrese et al., 2000, Int J Cancer 85:545-554.
Perillo et al., 1998, J Mol Med 76:402-412.
Pflugfelder, 2003, The Ocular Surface, 1:31-36.
Rolando et al., 2001, Surv Ophthalmol 45:S203-S210.
Schein et al., 1997, Am J Ophthamol 124:723-728.
Seelenmeyer et al., 2003, J Cell Sci, 116:1305-1318.
Seetharaman et al., 1998, J Biol Chem 273:13047-13052.
Singh et al., 1989, Cornea 8:45-53.
Timmons et al., 1999, Int J Dev Biol 43:229-235.
Wang et al., 1995, Biochem Biophys Res Commun 217:292-303.
Warfield et al., 1997, Invasion Metastasis 17:101-112.
Watanabe, 2002, Cornea 21:S17-S22.
Yang et al., 1998, Biochemistry 37:4086-4092.
Zoukhri et al., 2001, Invest Ophthalmol Vis Sci 42:925-932.

Affiliated with

Also associated with

Rating

Compositions and uses of a galectin for treatment of dry eye... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and uses of a galectin for treatment of dry eye..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and uses of a galectin for treatment of dry eye... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3768740